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Ventriculoperitoneal shunts (VPSs) are used for the treatment of hydrocephalus.  Here we analyzed the 
outcomes of VPS placements in 24 infants to determine the risk factors for shunt failure.  The infants 
had undergone the initial VPS operation in our hospital between March 2005 and December 2013.  They 
were observed until the end of January 2014.  We obtained Kaplan-Meier curves and performed a 
multivariate Cox regression analysis of shunt failure.  Of the 24 cases,  the median (range) values for 
gestational age,  birth weight,  and birth head circumference (HC) were 37 (27-39) wks,  2,736 (686-
3,788) g,  and 35.3 (23.0-45.3) cm,  respectively.  The total number of shunt procedures was 45.  Shunt 
failure rates were 0.51/shunt and 0.0053/shunt/year.  Shunt infection rates were 0.13/shunt and 0.0014/
shunt/year.  The Kaplan-Meier analysis revealed an increased risk for shunt failure in infants ＜1 
month old or in the HC ＞90ｵtile.  The Cox regression analysis yielded hazard ratios (HRs) of 2.93 
(95ｵ conﬁdence interval (CI),  0.96-10.95,  p＝0.059) for age ＜1 month,  and 4.46 (95ｵCI: 1.20-28.91,  
p＝0.023) for the HC ＞90ｵtile.  The multivariate Cox regression analysis showed adjusted HRs of 
17.56 (95ｵCI: 2.69-202.8,  p＝0.001) for age ＜1 month,  and 2.95 (95ｵCI: 0.52-24.84,  p＝0.228) for the 
HC ＞90ｵtile.  Our ﬁndings thus revealed that the risk factors for shunt failure in infants include age 
＜1 month at the initial VPS placement.
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he use of ventriculoperitoneal shunts (VPSs) 
for the treatment of hydrocephalus poses the 
risk of shunt failure due to infection or obstruction.  
Shunt failure rates have been reported to range from 
20ｵ to 70ｵ [1-4],  with risk factors including young 
age,  male,  and socioeconomic status [5].  Shunt 
infection rates have been reported to range from 8ｵ 
to 20ｵ [6-13],  with risk factors including prematu-
rity [6,  8,  10],  previous shunt infection [10,  12],  
postoperative cerebrospinal ﬂuid (CSF) leaks [8],  
and young age [11-13].  Shunt failure,  particularly 
that due to infection,  remains a signiﬁcant problem in 
neurological surgery.  This study assessed the out-
comes of infantile VPS placement to determine the 
risk factors for shunt failure.
Patients and Methods
　 We conducted a retrospective cohort study in 
infants with VPSs who were admitted to the tertiary 
neonatal intensive care unit at Kochi Health Sciences 
Center between March 1,  2005 and December 31,  
2013.  The inclusion criteria required the infants to 
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have had an initial VPS placement at the study hospi-
tal within 1yr after birth.  Infants who had undergone 
an intracranial operation before their initial VPS 
placement were excluded.  The study observation 
period continued through January 31,  2014.
　 Perinatal and neonatal data were collected at and 
after birth,  including birth characteristics (sex,  ges-
tational age [GA],  birth weight [BW],  and head 
circumference [HC]),  causes of hydrocephalus (aque-
ductal stenosis,  brain tumor,  CSF infection,  head 
injury,  intraventricular hemorrhage,  myelomeningo-
cele,  or other/unknown),  VPS-related factors at the 
time of placement (age,  weight,  HC,  insertion site,  
operator,  HC change after operation,  and complica-
tions within 1wk after the operation).  After the initial 
VPS placement,  the patients were monitored for 
shunt failure.  Ventriculoatrial shunts were consid-
ered VPSs.  Shunt failure rates and infection rates 
were calculated for all VPSs.
　 We generated Kaplan-Meier survival curves to 
estimate the risk of shunt failure.  In addition,  hazard 
ratios (HRs),  corresponding 95ｵ conﬁdence intervals 
(95ｵ CIs),  and p-values were calculated using uni-
variate and multivariate Cox regression analyses.  The 
following risk factors were used in the multivariate 
Cox regression analysis: male [2],  age ＜1 month,  
HC ＞90ｵtile at initial VPS placement,  and occipital 
insertion [3].  Participating infants were divided by 
age at the time of the initial VPS placement,  with age 
groups consisting of “＜1 month” and “ｧ1 month,” 
because younger age was considered to be a risk fac-
tor [5].  The additional risk factor of HC ＞90ｵtile 
was also included.  Although none of the previous 
studies reviewed had addressed this risk factor for 
shunt failure,  macrocephaly is related to the severity 
of the disease.  P-values ＜0.05 were considered sig-
niﬁcant.
　 Shunt failure was deﬁned as the need for any sub-
sequent surgical procedure for deﬁnitive CSF diver-
sion (due to shunt malfunction or infection),  or death 
associated with hydrocephalus management [14].  A 
veriﬁed diagnosis of shunt infection required at least 
one of the following criteria: surgical wound infection 
or wound breakdown; positive CSF culture from shunt 
aspirate obtained using sterile procedures; bacteremia 
in patients with ventriculoatrial shunts; and peritoneal 
infection in patients with VPS [8].  The HC reduction 
rate was deﬁned as follows:
HC reduction rate＝
(HC at initial VPS placement－Minimum HC within 3 
days after initial VPS placement)/HC at initial VPS 
placement
　 Statistical analyses were performed using JMP 
10.0.2 software (SAS Institute,  Cary,  NC,  USA).  
This study was approved by the Institutional Review 
Board of the Kochi Health Sciences Center.
Results
　 A total of 24 infants were evaluated in this study 
(Table 1),  13 (54ｵ) of whom were male.  The median 
(range) values for GA,  BW,  and birth HC were 
37wks＋4 days (27wks＋1 day to 39wks＋5 days,  
n＝23),  2,736g (686－3,788g,  n＝23),  and 35.3cm 
(23.0－45.3cm,  n＝20),  respectively.  The causes of 
hydrocephalus were: myelomeningocele (n＝10),  
aqueductal stenosis (n＝6),  interhemispheric cyst 
(n＝2),  prematurity (n＝2),  tumor (n＝1),  Dandy-
Walker syndrome (n＝1),  and unknown (n＝2).  The 
median (range) values for age,  weight,  and HC at the 
initial VPS placement were 0 month (0-11 months),  
3.3kg (2.2-10.2kg),  and 39.5cm (33.5-49.4cm,  n＝22),  
respectively.
　 The number of participants ＜1 month old was 15 
(63ｵ).  The number of participants in the HC ＞90ｵ
tile at the initial VPS placement was 15 (68.2ｵ,  
n＝22).  The number of occipital insertions of initial 
VPSs was 17 (71ｵ).  The major surgeon was A,  who 
operated on 20 cases (83ｵ).  The complications that 
occurred within 1wk after the initial VPS insertion 
were: CSF leakage (n＝7),  including 1 case with 
fever,  intracranial hemorrhage (n＝3),  subdural 
hygroma (n＝1),  and none (n＝14).  For the three 
intracranial hemorrhage cases,  the HC reduction 
ratios were 6.7ｵ and 9.1ｵ (the data of one case were 
missing).  The mean (standard deviation [SD]) value of 
HC reduction in the infants without hemorrhage was 
1.1ｵ (3.1ｵ) (n＝12).
　 The median (range) observation period following 
the initial VPS placement was 52 (1-99) months,  with 
a total observation period of 1,147 months.  Three 
cases were censored,  including one infant who passed 
away due to causes unrelated to VPS,  and 2 infants 
who were transferred.
　 The total number of VPSs was 45,  with a shunt 
failure rate of 51.1ｵ/shunt,  or 0.53ｵ/shunt/year.  
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The shunt infection rate was 13.3ｵ/shunt,  or 0.14ｵ/
shunt/year.  The number of shunt failures occurring 
within 6 months of initial VPS placement was eight.  
The causes of failure were: obstruction (n＝3),  
infection (n＝2),  migration (n＝2) (Fig.  1),  and inser-
tion to the inferior horn (n＝1) (Fig.  2).  The caus-
ative organisms in both infection cases were found to 
be coagulase-negative Staphylococci.  One infection 
case and both migration cases had CSF leakage.  No 
clear causes were identiﬁed for the shunt obstruction 
and the insertion to the inferior horn.
　 We performed a Kaplan-Meier analysis to evaluate 
the probability of failure-free survival (Fig.  3).  Clear 
diﬀerences regarding age and HC at initial VPS 
placement were revealed by the analysis.  There was 
an increased risk of VPS failure in both the infants 
＜1 month old compared to those ｧ1 month old,  and 
among the infants in the HC ＞90ｵtile compared to 
those in the ｦ90ｵtile.
　 The Cox regression analysis yielded HR values of 
2.93 (95ｵCI: 0.96-10.95,  p＝0.059) for age ＜1 
month and 4.46 (95ｵCI: 1.20-28.91,  p＝0.023) for 
the HC ＞90ｵtile (Table 2).  The survival curves for 
sex and insertion site crossed each other.  The multi-
variate analysis showed adjusted HR values of 0.15 
(95ｵCI: 0.03-0.57,  p＝0.006) for male sex,  17.56 
(95ｵCI: 2.69-202.8,  p＝0.001) for age ＜1 month,  
2.95 (95ｵCI: 0.52-24.84,  p＝0.228) for the HC 
＞90ｵtile,  and 0.64 (95ｵCI: 0.18-2.44,  p＝0.494) 
for occipital VPS insertion (Table 3).  This result 
showed that the factors of sex and age made a signiﬁ-
cant diﬀerence,  and that the HR for males was greatly 
decreased.  There were 2 cases with missing data of 
HC at the initial VPS placement.  We performed the 
sensitivity analysis by imputing tentative data: the 
adjusted HRs for male sex were from 0.19 to 0.46 
(p＝0.010 to 0.155).
Discussion
　 According to the results of our multivariate Cox 
regression analysis,  the risk factors for shunt failure 
include female sex and age ＜1 month at the initial 
VPS placement.  A previous study found that patients 
＜1 month old had an increased risk of shunt failure 
[5].  This age factor would be related to poorly devel-
oped humoral and cellular immune systems,  the 
immaturity of the skin barrier,  and the feature of 
90 Acta Med.  Okayama　Vol.  69,  No.  2Maruyama et al.
Fig. 2　 The tip of the shunt was found in the inferior horn by 
head computed tomography in this 16-day-old male infant.
Fig. 1　 Shunt migration was found at the posterior head by X-ray 
in this 2-month-old female infant.
residential bacterial ﬂora [9].  Etiological factors 
must also be considered.  The main causes of hydro-
cephalus in the present study,  dealing with infantile 
cases,  were myelomeningocele (10 of 24,  42ｵ) and 
aqueductal stenosis (6 of 24,  25ｵ).  Previous studied 
found the rates of childrenʼs diseases requiring VPS 
to be: myelomeningocele (15.6ｵ),  aqueductal stenosis 
(8.0ｵ),  post-hemorrhage (24.8ｵ),  and brain tumor 
(18.1ｵ) [14].  The disease spectrum of the present 
study diﬀered somewhat.
　 In their shunt infection rate study,  Kulkarni et al.  
reported myelomeningocele,  4.6ｵ; aqueductal steno-
sis,  12.5ｵ; intraventricular hemorrhage,  17.5ｵ and 
tumor,  9.5ｵ [8].  McGirt et al.  found myelomenin-
gocele,  10.3ｵ; idiopathic/congenital,  13.0ｵ; intra-
ventricular hemorrhage,  16.7ｵ; and tumor,  3.3ｵ 
[10].  From these reports,  we could not say that 
myelomeningocele was a risky etiology.  Our Kaplan-
91Infantile VPS OutcomesApril 2015
Table 2　 Univariate Cox regression analysis for shunt failure
HR 95%CI p
Male 0.69 0.25-1.91 0.472
Age ＜1 month 2.93 0.96-10.95 0.059
HC ＞90%tile (n＝22) 4.46 1.20-28.91 0.023
Occipital insertion 1.01 0.36-3.20 0.991
Table 3　 Multivariate Cox regression analysis for shunt failure
Adjusted HR 95%CI p
Male 0.15 0.03-0.57 0.006
Age ＜1 month 17.56 2.69-202.82 0.001
HC ＞90%tile (n＝22)  2.95 0.52-24.84 0.228
Occipital insertion  0.64 0.18-2.44 0.494
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Fig. 3　 Kaplan-Meier survival analysis for shunt failure.  A,  Failure-free curves categorized by sex.  Solid line” males (n＝13); dashed 
line” females (n＝11); B,  Failure-free curves categorized by age at initial VPS placement.  Solid line: ＜1 month (n＝15); dashed line:
ｧ1 month (n＝9); C,  Failure-free curves categorized by HC at initial VPS placement. Solid line: HC ＞90%tile (n＝15); dashed line:
ｦ90%tile (n＝7); D,  Failure-free curves categorized by insertion site at initial VPS placement. Solid line: occipital insertion (n＝17);  
dashed line: frontal insertion (n＝7).
Meier analysis results indicated that the HC ＞90ｵ
tile was also an important factor for shunt failure.  Out 
of 15 patients shunted at ＜1 month,  there were 11 
patients in the HC ＞90ｵtile,  and 10 shunt failures 
occurred afterwards.  Clinicians should therefore 
exercise even greater care for patients who need a 
VPS at ＜1 month of age when they are in the HC 
＞90ｵtile.
　 A previous study showed male preponderance in 
shunt failure [2],  but that study included adult 
patients.  Other studies dealing with children showed 
that the male risk ratios were 1.24 (95ｵCI: 0.63-
2.47) [9] and 1.14 (p＝0.5337) [15].  These data 
indicate that there was no signiﬁcant diﬀerence 
between the male and female patients.  Although our 
present sensitivity analysis showed that female sex 
might be a risk factor for shunt failure,  we were 
unable to ﬁnd any reports of female preponderance.
　 The present rates of shunt failure [1-4] and shunt 
infection [6-13] were within the range found by pre-
vious studies.  One of our patients with infection 
experienced CSF leakage,  a risk factor for infection 
[8].  Both of the present patients with infection expe-
rienced fever at the beginning of the infection,  an 
important sign of increased risk.  The cause of infec-
tion in both cases was coagulase-negative Staphylococci,  
which was cultured from a preoperative skin culture.  
Although prophylactic antibiotics can be administered 
intravenously in such cases,  one report described the 
injection of prophylactic vancomycin into the ventricle 
[2].
　 Both of our migration cases had CSF leakage.  
Many hypotheses have been reported regarding the 
upward migration of distal shunt tubing.  One of them 
is the “windlass eﬀect, ” in which granulation tissue or 
a valve placed below the scalp acts as an anchoring 
point and the patientʼs repeated head motion allows the 
distal tubing to be pulled in a proximal direction [16].  
Shahsavaran et al.  described a case in which subgaleal 
CSF collected in the suction catheter [17].  Subcuta-
neous ﬂuid collection might be a risk factor for migra-
tion.
　 Insertion to the inferior horn could happen during 
tube insertion via the occipital site.  Parieto-occipital 
entry was also indicated as a risk factor (p＝0.09) 
[3].  The results of the present study,  however,  
showed no signiﬁcant diﬀerence in risk between fron-
tal and occipital insertions.
　 The rate of intracranial hemorrhage in previous 
reports was 1.1ｵ-4ｵ [18-20].  The intracranial 
hemorrhage rate in the present study (3 of 24 
patients,  13ｵ) was markedly higher.  Hemorrhage 
may be caused by multiple attempts at perforation of 
the ventricles,  puncture of the choroid plexus,  or 
improper placement of the tubing within the paren-
chyma of the brain [18].  The rate of HC reduction 
was high among the present cases with hemorrhages,  
although this parameter has not yet been investigated 
fully.  The rapid excretion of CSF may cause a rapid 
decrease in intracranial pressure,  and rapid HC 
reduction should be closely monitored.
　 The primary limitations of this study were its small 
sample size,  inadequate statistical analysis,  and dif-
ferent spectrum of related diseases.  Thus,  each case 
was evaluated independently,  in addition to the overall 
statistical analysis.
　 In conclusion,  the results of this study revealed 
that the risk factors for shunt failure include age ＜1 
month at the initial VPS placement.  The HC ＞90ｵ
tile at the initial VPS placement could also be an 
important factor.  Although there was not a high rate 
of shunt failure in this patient series,  each infant must 
be treated according to his or her risk factors.
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